Target intelligence / Profile preview

Novel transcript, antisense to RASSF3 (ENSG00000256199)

Target
ENSG00000256199
Molecular classification
Non-coding RNA, Natural antisense transcript (NAT)
01

Overview

ENSG00000256199 is annotated as a "novel transcript, antisense to RASSF3" and classified as a non-coding natural antisense RNA (NAT). Antisense transcripts are a common genomic feature in eukaryotes, frequently overlapping with protein-coding genes on the opposite DNA strand[2][3]. These RNAs regulate gene expression by mechanisms such as RNA masking, transcriptional interference, or RNA interference, often leading to alterations in the stability, splicing, or translation of the sense (protein-coding) transcript[2][3]. There is no evidence that ENSG00000256199 encodes a protein or functions as a receptor, enzyme, or druggable molecular target. Instead, its primary role is likely to influence the expression of the adjacent RASSF3 tumor suppressor gene. While antisense RNAs can have significant biological roles and may be therapeutically relevant in the future, this specific antisense transcript is not currently considered a direct target for existing drugs or therapies[2][4].

Other names
Antisense RNA to RASSF3
02

Biological functions

Regulation of gene expressionPotential RNA interference or RNA masking of RASSF3 expression
03

Disease associations

Other

Beyond the preview

Go deeper on Novel transcript, antisense to RASSF3 (ENSG00000256199).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to RASSF3 (ENSG00000256199).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call